Latest Articles
-
Will Merck Stock Rise After Its Q1 Results?
Merck (NYSE: MRK) is scheduled to report its Q1 2022 results on Thursday, Apr 28. We expect MRK stock to trend higher in the near term due to a strong Q1, with revenue falling in-line and earnings expected to be comfortably above the consensus ...
-
Company Of The Day: Merck
What? Merck (NYSE:MRK) and AstraZenica’s cancer drug Lynparza has been approved by the U.S. FDA to treat patients with early-stage breast cancer with certain mutations. So What? Merck’s alliance revenue from Lynparza stood at abou...
-
What’s Next For Merck Stock After A 6% Fall In A Month?
The stock price of Merck (NYSE: MRK) has seen a fall of 6% over the last month, while it is down 1% year-to-date. This marks a better performance than the broader markets, with the S&P500 down 6% over the last month but down 10% so far this...
-
Will Merck Stock Rise After Its Q4 Results?
Merck (NYSE: MRK) is scheduled to report its Q4 2021 results on Thursday, Feb 3. We expect MRK stock to trend higher in the near term due to an upbeat Q4, with revenue and earnings expected to be comfortably above the consensus estimates, drive...
-
Here’s A Better Pharmaceutical Pick Over Merck Stock
We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer, Merck stock (NYSE: MRK), given its better growth prospects and comparatively lower valuation, with its stock trading at 3.0x trail...
-
What’s Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?
[Updated: Dec 1, 2021] Merck Covid-19 Pill Update Just a few days back we discussed that the stock price of Merck (NYSE: MRK) is being weighed down due to concerns around its Covid-19 antiviral pill – Molnupiravir – which has an ef...
-
Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?
[Updated: Nov 29, 2021] Merck Covid-19 Pill Update The stock price of Merck (NYSE: MRK) has seen an 8% fall in a month, while it was down nearly 4% on Friday, Nov 26. This can largely be attributed to the company’s recently shared data f...
-
What’s Next For Merck Stock After An Upbeat Q3?
[Updated: Nov 3, 2021] MRK Stock Update Merck (NYSE: MRK) recently reported its Q3 results, which were better than our estimates. The company reported sales of around $13.2 billion (up 20% y-o-y), compared to our estimate of $12.2 billion. Whi...
-
Company Of The Day: Merck
What? Merck (NYSE:MRK) posted a stronger than expected set of Q3 2021 results, with revenue rising by about 20% year-over-year to $13.15 billion and adjusted EPS rising 28% to $1.75. The company also raised its full-year revenue guidance to bet...
-
What To Expect From Merck’s Q3?
Merck (NYSE: MRK) is scheduled to report its Q3 2021 results on Thursday, October 28. We expect the company to likely post revenue and earnings below the consensus estimates, as the spread of Covid-19 delta variant likely impacted the company&#...
-
Company Of The Day: Merck
What? Merck (NY SE: MRK) announced an agreement with Singapore to provide access to its experimental oral Covid-19 antiviral drug, molnupiravir. Australia has already ordered 300,000 courses of the drug, while Thailand, South Korea, Taiwan, a...
-
Here’s Why Merck Stock May Continue To Rise
[Updated: Oct 4, 2021] Merck Stock Rise The stock price of Merck (NYSE: MRK) surged 8% to levels of $81 on Friday, Oct 1, after the company announced that its Molnupiravir pill reduces the risk of hospitalization and death by 50% for patients ...
-
With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision
[Updated: Oct 1, 2021] Merck To Acquire Acceleron Merck (NYSE: MRK) yesterday announced that it will acquire Acceleron Pharma – a biopharmaceutical company focused on rare diseases – for $11.5 billion funded in cash and debt. Accel...
-
Company Of The Day: Merck
What? The Wall Street Journal reports that Merck (NYSE:MRK) is looking to buy Acceleron Pharma, in a deal that could be announced as soon as this week. Why? A deal could bolster Merck’s rare diseases business. Acceleron’s most high...
-
Should You Buy Merck Stock At $72?
The stock price of Merck (NYSE: MRK) reached its 52-week high of around $82 in Sep 2020. It has since hovered in the range of $70-80 for the better part of the last year, and it currently trades at levels of around $72. We believe that MRK sto...
